Editas Medicine, Inc. Annual Depreciation in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Editas Medicine, Inc. quarterly/annual Depreciation history and growth rate from 2014 to 2023.
  • Editas Medicine, Inc. Depreciation for the quarter ending March 31, 2024 was $1.41M, a 8.74% decline year-over-year.
  • Editas Medicine, Inc. annual Depreciation for 2023 was $6.06M, a 4.31% decline from 2022.
  • Editas Medicine, Inc. annual Depreciation for 2022 was $6.34M, a 25.4% increase from 2021.
  • Editas Medicine, Inc. annual Depreciation for 2021 was $5.05M, a 27.6% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $6.06M -$273K -4.31% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $6.34M +$1.28M +25.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $5.05M +$1.09M +27.6% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $3.96M +$1.13M +39.9% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-22
2019 $2.83M -$424K -13% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 $3.25M +$571K +21.3% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 $2.68M +$1.48M +123% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
2016 $1.2M +$731K +155% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 $471K +$314K +200% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-08
2014 $157K Jan 1, 2014 Dec 31, 2014 10-K 2017-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.